Skip to main content
. 2021 Feb 11;12:627493. doi: 10.3389/fneur.2021.627493

Table 3.

Efficacy outcomes of the patients who underwent EVT (alone or combined with IVT) during the two study periods.

Outcome 23rd March to 30th June 2020 (n = 57) 23rd March to 30th June 2019 (n = 44) P
mRS at 90 days, (median, IQR) 3; 0–6 3; 0–6 0.403
Functional independence at 90 days [mRS 0–2, n (%)] 20 (35.09%) 15 (34.09%) 0.367
Death at 90 days 12 (21.05%) 15 (34.09%) 0.283

mRS, modified Rankin Scale; IQR, interquartile range.